ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$453M |
| 2 |
UiPath
PATH
|
+$149M |
| 3 |
Roku
ROKU
|
+$135M |
| 4 |
Zoom
ZM
|
+$125M |
| 5 |
Ginkgo Bioworks
DNA
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGFY
Signify Health, Inc.
SGFY
|
+$456M |
| 2 |
Spotify
SPOT
|
+$133M |
| 3 |
Stratasys
SSYS
|
+$118M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$108M |
| 5 |
Coinbase
COIN
|
+$86.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.12% |
| 2 | Technology | 30.32% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Communication Services | 8.53% |
| 5 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.2T
| $1.08B | 7.54% |
4,080,917
-250,102
| -6% | -$69.8M |
|
|
2
Zoom
ZM
$26.3B
| $801M | 5.59% |
10,891,340
+1,315,322
| +14% | +$125M |
|
|
3
Roku
ROKU
$21.3B
| $672M | 4.69% |
11,917,866
+1,773,302
| +17% | +$135M |
|
|
4
UiPath
PATH
$5.98B
| $581M | 4.05% |
46,084,074
+8,488,829
| +23% | +$149M |
|
|
EXAS
5
DELISTED
Exact Sciences
EXAS
| $571M | 3.98% |
17,561,702
+2,589,937
| +17% | +$107M |
|
6
Intellia Therapeutics
NTLA
$1.43B
| $540M | 3.77% |
9,657,052
+142,472
| +1% | +$8.84M |
|
|
7
CRISPR Therapeutics
CRSP
$4.55B
| $538M | 3.75% |
8,237,122
-1,490,409
| -15% | -$108M |
|
8
Teladoc Health
TDOC
$1.59B
| $529M | 3.69% |
20,858,302
+564,340
| +3% | +$19.8M |
|
|
XYZ
9
Block Inc
XYZ
$48.3B
| $505M | 3.52% |
9,191,790
+56,211
| +0.6% | +$3.98M |
|
|
10
Coinbase
COIN
$42.8B
| $498M | 3.47% |
7,717,135
-1,234,090
| -14% | -$86.2M |
|
11
Twilio
TWLO
$29B
| $472M | 3.29% |
6,826,631
+1,254,195
| +23% | +$100M |
|
12
Beam Therapeutics
BEAM
$2.58B
| $405M | 2.82% |
8,490,936
-301,128
| -3% | -$17.2M |
|
|
13
Ginkgo Bioworks
DNA
$482M
| $396M | 2.76% |
3,170,471
+986,520
| +45% | +$118M |
|
|
14
Shopify
SHOP
$168B
| $392M | 2.73% |
14,532,528
+13,319,042
| +1,098% | +$453M |
|
15
DraftKings
DKNG
$12B
| $374M | 2.61% |
24,707,394
-568,419
| -2% | -$9.03M |
|
16
Unity
U
$13B
| $359M | 2.5% |
11,263,159
+2,087,448
| +23% | +$85.9M |
|
17
Robinhood
HOOD
$80B
| $332M | 2.32% |
32,910,470
-646,319
| -2% | -$6.21M |
|
18
Roblox
RBLX
$34.5B
| $304M | 2.12% |
8,474,696
+1,069,592
| +14% | +$44.2M |
|
19
Fate Therapeutics
FATE
$266M
| $261M | 1.82% |
11,655,833
+182,178
| +2% | +$5.26M |
|
20
PagerDuty
PD
$764M
| $250M | 1.74% |
10,821,427
-61,552
| -0.6% | -$1.59M |
|
21
Twist Bioscience
TWST
$5.33B
| $235M | 1.64% |
6,676,908
+409,187
| +7% | +$17.4M |
|
22
NVIDIA
NVDA
$4.71T
| $168M | 1.17% |
13,826,240
+7,067,380
| +105% | +$112M |
|
23
Pacific Biosciences
PACB
$422M
| $167M | 1.16% |
28,692,494
+646,964
| +2% | +$3.71M |
|
24
Ionis Pharmaceuticals
IONS
$9.14B
| $164M | 1.14% |
3,713,107
-988,190
| -21% | -$41.6M |
|
25
Veracyte
VCYT
$4.48B
| $151M | 1.05% |
9,081,363
+225,118
| +3% | +$5.07M |
|
Similar funds
ARK Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, ARK Investment Management held 361 positions worth $14.3B, down 15% from $16.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
ARK Investment Management's Q3 2022 filing shows 10 new, 102 increased, 126 reduced and 111 closed positions. Its largest new stake was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M. The largest sale was Signify Health, Inc., an estimated $456M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
- ARK Investment Management's largest Q3 2022 buy was SomaLogic, Inc. Class A Common Stock: 11,017,672 shares worth $32M.
- ARK Investment Management added most to Shopify in Q3 2022, an estimated $453M increase.
- ARK Investment Management's biggest Q3 2022 reduction was Signify Health, Inc., cutting an estimated $456M.
- ARK Investment Management fully exited 1Life Healthcare in Q3 2022, selling an estimated $49.1M.
- ARK Investment Management's ten largest holdings make up 44% of its $14.3B portfolio in Q3 2022.
- ARK Investment Management opened 10 new positions and closed 111 in Q3 2022.
- ARK Investment Management's portfolio value fell 15% quarter-over-quarter to $14.3B.
Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.